SINAGRA, GIANFRANCO
 Distribuzione geografica
Continente #
EU - Europa 23.186
NA - Nord America 9.047
AS - Asia 3.791
AF - Africa 315
OC - Oceania 196
SA - Sud America 195
Continente sconosciuto - Info sul continente non disponibili 7
Totale 36.737
Nazione #
IT - Italia 18.756
US - Stati Uniti d'America 8.811
CN - Cina 2.264
FR - Francia 1.202
DE - Germania 890
GB - Regno Unito 452
IN - India 337
NL - Olanda 247
VN - Vietnam 221
JP - Giappone 208
PL - Polonia 175
CA - Canada 173
ES - Italia 158
AU - Australia 154
RU - Federazione Russa 138
CH - Svizzera 117
UA - Ucraina 117
CZ - Repubblica Ceca 110
HK - Hong Kong 105
SE - Svezia 101
ZA - Sudafrica 93
ID - Indonesia 88
EG - Egitto 86
BE - Belgio 67
LV - Lettonia 66
KR - Corea 64
BR - Brasile 63
FI - Finlandia 61
IE - Irlanda 57
TR - Turchia 55
GR - Grecia 54
PT - Portogallo 53
AT - Austria 45
TH - Thailandia 44
DK - Danimarca 43
IR - Iran 43
RO - Romania 43
MY - Malesia 41
NZ - Nuova Zelanda 40
PK - Pakistan 40
AR - Argentina 38
CL - Cile 33
SG - Singapore 33
TW - Taiwan 33
MX - Messico 32
AE - Emirati Arabi Uniti 31
CO - Colombia 31
HR - Croazia 30
PH - Filippine 29
RS - Serbia 26
ET - Etiopia 22
HU - Ungheria 22
IL - Israele 22
SA - Arabia Saudita 21
AL - Albania 20
SK - Slovacchia (Repubblica Slovacca) 20
LT - Lituania 19
NO - Norvegia 19
BA - Bosnia-Erzegovina 17
SN - Senegal 17
BG - Bulgaria 16
IQ - Iraq 16
NG - Nigeria 16
PE - Perù 16
MK - Macedonia 14
BD - Bangladesh 12
MA - Marocco 11
TN - Tunisia 11
JO - Giordania 10
UZ - Uzbekistan 9
DZ - Algeria 8
EC - Ecuador 7
SM - San Marino 7
CI - Costa d'Avorio 6
LB - Libano 6
LU - Lussemburgo 6
SD - Sudan 6
CG - Congo 5
CR - Costa Rica 5
GH - Ghana 5
KG - Kirghizistan 5
LK - Sri Lanka 5
LY - Libia 5
OM - Oman 5
SI - Slovenia 5
XK - ???statistics.table.value.countryCode.XK??? 5
YE - Yemen 5
AF - Afghanistan, Repubblica islamica di 4
AZ - Azerbaigian 4
CD - Congo 4
CU - Cuba 4
DO - Repubblica Dominicana 4
NP - Nepal 4
PA - Panama 4
VE - Venezuela 4
CY - Cipro 3
KE - Kenya 3
KZ - Kazakistan 3
MD - Moldavia 3
MT - Malta 3
Totale 36.671
Città #
Milan 1.889
Rome 1.773
Trieste 1.276
Ashburn 1.138
Beijing 1.056
Fairfield 847
Naples 565
Woodbridge 496
Seattle 474
Houston 461
Turin 439
Santa Cruz 376
Buffalo 358
Bologna 353
Florence 318
Cambridge 302
Palermo 300
Ann Arbor 270
Bari 247
Wilmington 247
Catania 240
Padova 229
Boardman 213
Genoa 209
Verona 178
Dong Ket 162
Udine 151
Chicago 150
Fleming Island 150
Shanghai 146
Paris 144
Brescia 125
Warsaw 122
Perugia 99
London 94
Los Angeles 93
Messina 93
Pisa 86
Parma 85
Cagliari 81
Guangzhou 72
New York 71
Ancona 70
Venezia 70
Bergamo 69
Mountain View 67
Amsterdam 65
Bengaluru 62
Salerno 62
Las Vegas 61
San Diego 59
Venice 59
Hangzhou 58
Modena 58
Sassari 58
Pescara 57
Monza 56
Rimini 56
Brooklyn 55
Council Bluffs 55
Livorno 55
Muizenberg 55
Vicenza 53
Wuhan 53
Avellino 51
Novara 51
Treviso 51
Reggio Calabria 50
University Park 50
Tokyo 48
Ottawa 47
Cairo 45
Dublin 45
Henderson 45
Riga 44
San Francisco 44
Atlanta 41
Foggia 41
Phoenix 41
Reggio Emilia 41
Toronto 41
Cedar Knolls 39
Des Moines 39
Milpitas 38
Mumbai 38
Pavia 38
Central 37
Giulianova 37
Trento 37
Campobasso 35
Helsinki 35
Melbourne 35
Zhengzhou 35
Lucca 34
Frankfurt am Main 33
Brindisi 32
Dallas 32
Philadelphia 32
Taranto 32
Clearwater 31
Totale 18.936
Nome #
Facciamo il punto: miocardio non compatto, file e2913fdf-368c-f688-e053-3705fe0a67e0 3.854
Documento di consenso ANMCO/FADOI/SIAARTI/SIC/SIMG/SIMI/SIMEU: Il percorso clinico-diagnostico e terapeutico del paziente con scompenso cardiaco acuto dal domicilio alla dimissione dal Pronto Soccorso/ Dipartimento di Emergenza-Accettazione, file e2913fdf-32ce-f688-e053-3705fe0a67e0 3.634
Iperpotassiemia nello scompenso cardiaco: nuove soluzioni per un vecchio problema, file e2913fdf-492e-f688-e053-3705fe0a67e0 3.369
Consulenza cardiologica e gestione perioperatoria del paziente cardiopatico. Protocollo dell’Azienda Sanitaria Universitaria Integrata di Trieste – Anno 2019, file e2913fde-f4ed-f688-e053-3705fe0a67e0 3.284
Insufficienza tricuspidale e indicazioni al trattamento, file e2913fdf-22d0-f688-e053-3705fe0a67e0 1.207
Takotsubo is not a cardiomyopathy, file e2913fdb-f033-f688-e053-3705fe0a67e0 510
Elevations of inflammatory markers PTX3 and sST2 after resuscitation from cardiac arrest are associated with multiple organ dysfunction syndrome and early death, file e2913fd9-e14c-f688-e053-3705fe0a67e0 376
Routine use of bilateral internal thoracic artery grafts for left-sided myocardial revascularization in insulin-dependent diabetic patients: early and long-term outcomes, file e2913fd9-9cbb-f688-e053-3705fe0a67e0 374
Value of Strain Imaging and Maximal Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy, file e2913fdb-f37e-f688-e053-3705fe0a67e0 344
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry, file e2913fdf-4f44-f688-e053-3705fe0a67e0 314
Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library, file 83471447-ebfe-4bbf-b843-55233129c309 288
Reference Values for Peak Exercise Cardiac Output in Healthy Individuals, file e2913fdc-0bfc-f688-e053-3705fe0a67e0 285
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score, file e2913fdc-f62b-f688-e053-3705fe0a67e0 272
Dilated Cardiomyopathy. From Genetics to Clinical Management, file e2913fdd-2423-f688-e053-3705fe0a67e0 262
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle, file e2913fdf-8ba6-f688-e053-3705fe0a67e0 258
A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies, file e2913fda-7ec2-f688-e053-3705fe0a67e0 255
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders, file e2913fde-f755-f688-e053-3705fe0a67e0 247
Role of Titin Missense Variants in Dilated Cardiomyopathy, file e2913fda-06bf-f688-e053-3705fe0a67e0 243
Prognostic impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial, file e2913fdb-f733-f688-e053-3705fe0a67e0 236
Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis, file af5565cc-a6f4-41ab-aa45-9b162d772ff2 230
Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives, file e2913fdc-6ac9-f688-e053-3705fe0a67e0 226
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies, file ada7573b-88e5-40dd-9c1c-f795b21c97cd 223
The peculiar role of vitamin D in the pathophysiology of cardiovascular and neurodegenerative diseases, file dce9b366-97c0-4de0-98bf-43a42b103376 218
Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction, file 54424231-ca02-4118-b866-5d238370b25f 212
Multi-state modelling of heart failure care path: A population-based investigation from Italy, file e2913fdb-c6c6-f688-e053-3705fe0a67e0 208
Implantable cardioverter-defibrillator-computed respiratory disturbance index accurately identifies severe sleep apnea: The DASAP-HF study, file e2913fdb-fd1e-f688-e053-3705fe0a67e0 208
Exercise performance, haemodynamics, and respiratory pattern do not identify heart failure patients who end exercise with dyspnoea from those with fatigue, file e2913fdb-f72b-f688-e053-3705fe0a67e0 205
Cardiac Tumors: Diagnosis, Prognosis, and Treatment, file e2913fde-08b7-f688-e053-3705fe0a67e0 198
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry, file e2913fde-f4e7-f688-e053-3705fe0a67e0 189
Myocarditis in Clinical Practice, file e2913fdf-501f-f688-e053-3705fe0a67e0 187
Cardiac fluid dynamics meets deformation imaging, file e2913fdb-d621-f688-e053-3705fe0a67e0 184
Effect of prehospital treatment in STEMI patients undergoing primary PCI, file e2913fdf-6a23-f688-e053-3705fe0a67e0 184
Restrictive cardiomyopathy: definition and diagnosis, file a1ded043-40c4-47b3-80cc-0dee95734dcd 182
Natural History of Dilated Cardiomyopathy in Children, file e2913fda-8192-f688-e053-3705fe0a67e0 181
Genome-wide association meta-analysis of 30,000 samples identifies seven novel loci for quantitative ECG traits, file e2913fdc-d154-f688-e053-3705fe0a67e0 178
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study, file e2913fdc-4961-f688-e053-3705fe0a67e0 177
Is heart failure with preserved ejection fraction a ‘dementia’ of the heart?, file 37591231-4e0b-4510-b950-9f5a766aaa06 175
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study, file e2913fdc-4358-f688-e053-3705fe0a67e0 175
Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction, file e2913fdd-11db-f688-e053-3705fe0a67e0 173
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History, file e2913fdd-3de0-f688-e053-3705fe0a67e0 171
MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs, file e2913fdc-8c19-f688-e053-3705fe0a67e0 170
Intracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes., file e2913fd9-1915-f688-e053-3705fe0a67e0 169
Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias, file e2913fda-9b7d-f688-e053-3705fe0a67e0 169
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures, file e2913fdc-c669-f688-e053-3705fe0a67e0 163
Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology, file e2913fdf-4af1-f688-e053-3705fe0a67e0 154
Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry, file e2913fdc-f62a-f688-e053-3705fe0a67e0 152
Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy, file e2913fdb-c298-f688-e053-3705fe0a67e0 149
Left Ventricular Response to Cardiac Resynchronization Therapy: Insights From Hemodynamic Forces Computed by Speckle Tracking, file e2913fdc-9bab-f688-e053-3705fe0a67e0 148
Chapter 6: Clinical Presentation, Spectrum of Disease, and Natural History, file e2913fdd-1dc4-f688-e053-3705fe0a67e0 147
Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction, file e2913fdc-f9fb-f688-e053-3705fe0a67e0 144
Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure, file e2913fdb-cb11-f688-e053-3705fe0a67e0 142
Chapter 9: Endomyocardial Biopsy, file e2913fdc-da6d-f688-e053-3705fe0a67e0 142
Historical Terminology, Classifications, and Present Definition of DCM., file e2913fdc-ddd2-f688-e053-3705fe0a67e0 140
Glomerular filtration rate: A prognostic marker in atrial fibrillation-A subanalysis of the AntiThrombotic Agents Atrial Fibrillation, file e2913fdc-aa9f-f688-e053-3705fe0a67e0 139
Critical role of lysosomes in the dysfunction of human Cardiac Stem Cells obtained from failing hearts, file e2913fdf-09ea-f688-e053-3705fe0a67e0 139
FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy, file e2913fda-fba3-f688-e053-3705fe0a67e0 136
Chapter 13: Current Management and Treatment, file e2913fdd-055d-f688-e053-3705fe0a67e0 136
Simple scoring system to predict in-hospital mortality after surgery for infective endocarditis, file e2913fdb-ef1d-f688-e053-3705fe0a67e0 134
Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome-There is Meat on the Bone, file e2913fdd-28ae-f688-e053-3705fe0a67e0 134
Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata, file dd6c7b48-2891-46d0-bafb-8bf6302c9edf 132
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy, file e2913fdb-ef20-f688-e053-3705fe0a67e0 130
Pulmonary Embolism Presenting with Pulmonary Infarction: Update and Practical Review of Literature Data, file e2e5f834-3edb-4930-ad2d-6e740b305ae2 130
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality, file bb12205f-8a96-45f7-a87a-c3d4aec6cfbc 129
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study, file 275f565e-7f11-45d2-b2fb-df1c10eb9581 127
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry, file 3e7eefc1-5132-42c2-9726-179ab7427e0a 127
Myocarditis evolving in cardiomyopathy: When genetics and offending causes work together, file e2913fdd-1899-f688-e053-3705fe0a67e0 126
Autophagy and Inflammasome Activation in Dilated Cardiomyopathy, file e2913fdd-2d7a-f688-e053-3705fe0a67e0 123
Chapter 11: Regenerative Medicine and Biomarkers for Dilated Cardiomyopathy, file e2913fdd-2494-f688-e053-3705fe0a67e0 120
Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6, file e2913fdc-4aaa-f688-e053-3705fe0a67e0 119
Molecular and Cellular Mechanisms in Heart Failure, file e2913fdf-367d-f688-e053-3705fe0a67e0 118
Evidence of a double anaerobic threshold in healthy subjects, file d2df25dd-43cb-4fde-af30-a6a342d2a2ce 115
The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy, file e2913fdd-786e-f688-e053-3705fe0a67e0 114
Chapter 5: Genetics of Dilated Cardiomyopathy: Current Knowledge and Future Perspectives, file e2913fdd-055e-f688-e053-3705fe0a67e0 113
Detection of subjects with ischemic heart disease by using machine learning technique based on heart rate total variability parameters, file e2913fdd-f60b-f688-e053-3705fe0a67e0 113
Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors, file e2913fdc-e2e5-f688-e053-3705fe0a67e0 111
Chapter 12: Prognostic Stratification and Importance of Follow-Up, file e2913fdc-eb75-f688-e053-3705fe0a67e0 111
Chapter 3: Pathophysiology, file e2913fdd-03b2-f688-e053-3705fe0a67e0 108
Chapter 14: Unresolved Issues and Future Perspectives, file e2913fdd-2496-f688-e053-3705fe0a67e0 108
PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity, file e2913fdc-434b-f688-e053-3705fe0a67e0 107
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy, file e2913fdf-8687-f688-e053-3705fe0a67e0 106
Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences, file e2913fdd-55a0-f688-e053-3705fe0a67e0 105
Sex-Specific Prognostic Implications in Dilated Cardiomyopathy After Left Ventricular Reverse Remodeling, file e2913fde-0f8b-f688-e053-3705fe0a67e0 104
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach, file e2913fdd-2495-f688-e053-3705fe0a67e0 103
Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy, file e2913fdb-428c-f688-e053-3705fe0a67e0 96
Gene Therapy for the Heart Lessons Learned and Future Perspectives, file e2913fdf-3416-f688-e053-3705fe0a67e0 96
Pragmatic electrocardiogram tracings in non-ischaemic dilated cardiomyopathy: diagnostic and prognostic role, file 92ce5db7-d505-4631-8065-15f626ef5be1 95
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world, file e2913fdd-8efd-f688-e053-3705fe0a67e0 95
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy, file e2913fdd-52a2-f688-e053-3705fe0a67e0 92
Cardiac Magnetic Resonance in Primary Prevention of Sudden Cardiac Death, file e2913fdd-559e-f688-e053-3705fe0a67e0 92
Contemporary etiology and prognosis of dilated non-ischemic cardiomyopathy, file a4a4b25b-8c22-4c1b-8154-e162ac59a90b 91
Standardizing the role of endomyocardial biopsy in current clinical practice worldwide, file 4b2c8317-9121-4273-8471-2c9e07d876fa 90
Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy, file 468c9389-c517-4b5d-aeca-999914bd5b8c 88
Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients, file e2913fdf-a324-f688-e053-3705fe0a67e0 88
Impact of patient delay in a modern real world STEMI network, file e2913fdf-4c57-f688-e053-3705fe0a67e0 84
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy, file b94d515a-becd-4903-a261-cc573898540d 82
Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study, file e2913fdf-31f2-f688-e053-3705fe0a67e0 82
Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era, file ffbaeba5-94e0-467f-b575-01d8d5893864 81
Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist?, file e2913fda-a49e-f688-e053-3705fe0a67e0 79
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy, file e2913fdd-c34a-f688-e053-3705fe0a67e0 78
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy, file e2913fde-bd7a-f688-e053-3705fe0a67e0 78
Totale 30.789
Categoria #
all - tutte 60.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.472


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019627 0 0 0 0 0 0 0 0 89 110 203 225
2019/20202.351 173 147 121 255 162 146 170 247 358 231 173 168
2020/20212.560 170 211 144 188 235 278 301 219 230 219 203 162
2021/20223.060 184 154 222 263 194 107 164 95 207 323 660 487
2022/202312.956 378 618 918 983 984 742 944 1.054 1.478 1.521 1.930 1.406
2023/202414.680 1.345 1.220 1.528 1.714 1.630 1.830 2.148 2.722 543 0 0 0
Totale 37.125